This inventor holds 3 USPTO granted patents. Top assignees: US Government as Represented by the Secretary of the Army, Research Triangle Institute. Active years: 1987-1991.
Company Filing History:
3 out of 8,742 
1 out of 359 
Years Active: 1987-1991
Title: Innovations of Peter K Chiang
Introduction
Peter K Chiang is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing novel antidotes for various medical conditions. With a total of 3 patents, his work has the potential to impact patient care significantly.
Latest Patents
Chiang's latest patents focus on the development of carbaphens, which are aprophen analogs that serve as binary antidotes. These novel carbaphens are characterized by specific chemical formulas, wherein R can be OH, OCON(CH.sub.3).sub.2, or OCONHCH.sub.3, and R' can be H, OH, or OCON(CH.sub.3).sub.2. The compositions include carbaphens combined with pharmaceutically acceptable carriers and may also incorporate other drugs. The methods outlined in his patents aim to treat patients suffering from organophosphate poisoning, coronary insufficiency, cerebral vasospasms, spastic cholitis, and cholecystitis through the administration of these innovative compounds.
Career Highlights
Throughout his career, Peter K Chiang has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and the Research Triangle Institute. His experience in these institutions has allowed him to contribute to significant advancements in medical research and pharmaceutical development.
Collaborations
Chiang has collaborated with notable colleagues, including Felipe N Padilla and Haim Leader. These partnerships have likely enhanced the scope and impact of his research endeavors.
Conclusion
Peter K Chiang's innovative work in developing carbaphens showcases his commitment to advancing medical treatments. His contributions to the field of pharmaceuticals are noteworthy and have the potential to improve patient outcomes significantly.